-
DMKPQ Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
DMK Pharmaceuticals (DMKPQ)
Company Profile
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 6.66 mm | 6.66 mm | 6.66 mm | 6.66 mm | 6.66 mm | 6.66 mm |
Cash burn (monthly) | (no burn) | (no burn) | 1.09 mm | 2.33 mm | 1.25 mm | 781.28 k |
Cash used (since last report) | n/a | n/a | 16.13 mm | 34.48 mm | 18.46 mm | 11.58 mm |
Cash remaining | n/a | n/a | -9.46 mm | -27.82 mm | -11.79 mm | -4.91 mm |
Runway (months of cash) | n/a | n/a | -8.7 | -12.0 | -9.5 | -6.3 |
13F holders | Current |
---|---|
Total holders | 26 |
Opened positions | 2 |
Closed positions | 26 |
Increased positions | 1 |
Reduced positions | 19 |
13F shares | Current |
---|---|
Total value | 283.37 mm |
Total shares | 6.85 mm |
Total puts | 0.00 |
Total calls | 38.61 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
CVI Investments | 4.92 mm | $2.39 mm |
Eses Holdings (FZE) | 1.64 mm | $4.33 mm |
Versi | 177.19 k | $443.00 k |
BLK BlackRock | 39.53 k | $95.27 mm |
Vanguard | 30.91 k | $74.49 mm |
Geode Capital Management | 18.95 k | $45.28 mm |
Cubist Systematic Strategies | 13.66 k | $32.91 mm |
Tower Research Capital | 6.97 k | $16.80 mm |
JPM JPMorgan Chase & Co. | 1.68 k | $4.03 mm |
MS Morgan Stanley | 1.36 k | $3.28 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Oct 23 | John W. Jr. Dorbin | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0.58 | 70,000 | 40.60 k | 70,000 |
16 Oct 23 | Seth Cohen | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0 | 151,416 | 0.00 | 151,416 |
15 Sep 23 | Ebrahim Versi | Common Stock | Conversion | Acquire C | Yes | No | 0 | 729,200 | 0.00 | 906,394 |
15 Sep 23 | Ebrahim Versi | Series E Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 729.2 | 0.00 | 1,212 |